Reference
- Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh I. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–5711. Beck A. T., Ward C. H., Mendelson M., Mock J., Erbaugh I. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
- Burgess C. D., Turner P., Wadsworth J. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br. J. Clin. Pharmacol. 1978; 5: 21S–28S, Suppl. 12. Burgess C. D., Turner P., Wadsworth J. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br. J. Clin. Pharmacol. 1978; 5: 21S–28S, Suppl. 1
- Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., de Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br. J. Psychiatry 1976; 129: 342–3453. Coppen A., Gupta R., Montgomery S., Ghose K., Bailey J., de Ridder J. J. Mianserin hydrochloride: a novel antidepressant. Br. J. Psychiatry 1976; 129: 342–345
- Coull D. C., Crooks J., Dingwall-Fordyce I., Scott A., Weir R. D. Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system. Lancet 1970; 2: 5904. Coull D. C., Crooks J., Dingwall-Fordyce I., Scott A., Weir R. D. Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system. Lancet 1970; 2: 590
- Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967; 6: 278–2965. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967; 6: 278–296
- Kristiansen E. S. Cardiac complications during treatment with imipramine. Acta Psychiatr. Neurol. 1961; 36: 427–4426. Kristiansen E. S. Cardiac complications during treatment with imipramine. Acta Psychiatr. Neurol. 1961; 36: 427–442
- Moir D. C., Crooks J., Cornwell W. B., O'Malley M., Dingwall-Fordyce I., Turnbull M. J., Weir R. D. Cardiotoxicity of amitriptyline. Lancet 1972; 2: 561–5647. Moir D. C., Crooks J., Cornwell W. B., O'Malley M., Dingwall-Fordyce I., Turnbull M. J., Weir R. D. Cardiotoxicity of amitriptyline. Lancet 1972; 2: 561–564
- Montgomery S. A., Burgess C. D., Montgomery D. B. Clinical and cardiac effects of mianserin and amitriptyline in depressed patients. Progress in the Pharmacotherapy of Depression: Mianserin HCl, G. Drykoningen, W. Linford, C. Rees Ruiz. Excerpta Medica, Amsterdam 1979; 60–64, Ogara. ICS 462.8. Montgomery S. A., Burgess C. D., Montgomery D. B. Clinical and cardiac effects of mianserin and amitriptyline in depressed patients. Progress in the Pharmacotherapy of Depression: Mianserin HCl, G. Drykoningen, W. Linford, C. Rees Ruiz. Excerpta Medica, Amsterdam 1979; 60–64, Ogara. ICS 462.
- Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night time and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S–76S, Suppl. 19. Montgomery S., McAuley R., Montgomery D. B. Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night time and divided daily dose regimens. Br. J. Clin. Pharmacol. 1978; 5: 71S–76S, Suppl. 1
- Montgomery S. A., Montgomery D. B., McAuley R., Rani S. J. Mianserin plasma levels and differential clinical response in endogenous and reactive depression. Acta Psychiatr. Belg. 1978; 78: 798–81210. Montgomery S. A., Montgomery D. B., McAuley R., Rani S. J. Mianserin plasma levels and differential clinical response in endogenous and reactive depression. Acta Psychiatr. Belg. 1978; 78: 798–812